title: Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease.
abstract: Human apolipoprotein E (apoE) has 3 isoforms: apoE2, apoE3, and apoE4. APOE4 is a major genetic risk factor for Alzheimer disease and is associated with dementia in Down syndrome and poor neurological outcome after traumatic brain injury, cerebral hemorrhage, and other neuropathological disorders. While apoE4 can induce neuropathology by participating in various cellular and molecular pathways, herein I review data supporting the hypothesis that apoE4 has direct toxic effects on the cerebrovascular system that in turn can lead to secondary neuronal dysfunction and degeneration as well as accumulation of neurotoxins in brain such as β-amyloid (Aβ) in Alzheimer disease. I review Aβ-independent cerebrovascular effects of apoE, particularly activation of a proinflammatory cyclophilin A-mediated pathway in brain vascular pericytes by apoE4 that has recently been shown to lead to a loss of cerebrovascular integrity and blood-brain barrier breakdown causing neuronal injury. I also review Aβ-dependent cerebrovascular effects of apoE such as faulty Aβ clearance from brain to circulation by apoE4. Finally, I discuss isoform-specific interactions of apoE with low-density lipoprotein receptor-related protein 1 on brain vascular cells (ie, endothelial cells, pericytes), which play an important role in Aβ-independent and Aβ-dependent effects of apoE on cerebral vasculature.
authors: Zilkha Neurogenetic Institute, 1501 San Pablo St, Room 101, Los Angeles, CA 90089, USA. berislav.zlokovic@med.usc.edu
authors: Berislav V
authors: BV
authors: Zlokovic
mesh_terms: D000544:Alzheimer Disease / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001057:Apolipoproteins E / Q000145:classification / Q000235:genetics*; D001812:Blood-Brain Barrier / Q000502:physiology*; D002560:Cerebrovascular Circulation / Q000235:genetics*; D021984:Cyclophilin A / Q000378:metabolism; D006801:Humans; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D001057:Apolipoproteins E; D016328:NF-kappa B; D020780:Matrix Metalloproteinase 9; D021984:Cyclophilin A
references: Cold Spring Harb Perspect Med. 2012 Oct 01;2(10):
references: 23028126
references: Neuron. 2010 Nov 4;68(3):409-27
references: 21040844
references: J Lipid Res. 2009 Apr;50 Suppl:S183-8
references: 19106071
references: Nat Rev Neurosci. 2011 Nov 03;12(12):723-38
references: 22048062
references: Neurobiol Aging. 2007 Jul;28(7):977-86
references: 16782234
references: Mol Psychiatry. 2011 Sep;16(9):903-7
references: 21556001
references: J Clin Invest. 2008 Dec;118(12):4002-13
references: 19033669
references: Neuron. 2009 Aug 13;63(3):287-303
references: 19679070
references: J Cereb Blood Flow Metab. 2007 May;27(5):909-18
references: 17077814
references: Nat Neurosci. 2011 Oct 26;14(11):1398-1405
references: 22030551
references: JAMA. 1997 Oct 22-29;278(16):1349-56
references: 9343467
references: N Engl J Med. 2013 Jan 10;368(2):107-16
references: 23150908
references: Lancet Neurol. 2011 Mar;10(3):241-52
references: 21349439
references: N Engl J Med. 2013 Jan 10;368(2):117-27
references: 23150934
references: Nature. 2012 May 16;485(7399):512-6
references: 22622580
references: J Neurochem. 1987 Jul;49(1):310-5
references: 3585338
references: Sci Transl Med. 2011 Jun 29;3(89):89ra57
references: 21715678
references: Brain Pathol. 2013 May;23(3):303-10
references: 23126372